'Pathbreaking' Ionis trial offers way forward in Huntington's disease

An experimental drug developed by Ionis Pharmaceuticals and Roche could offer a way forward to treat Huntington's disease, nearly three decades after researchers first pinpointed the gene behind the hereditary neurodegenerative disorder.